Hans-Peter Brecht, Chief Operating Officer of biomedical imaging firm PhotoSound Technologies, is working on the final development and commercialisation of a dual-modality ultrasound /photoacoustic imaging system called MoleculUS. 

Brecht says the MoleculUS could replace X-ray mammography with a noninvasive and painless procedure and reduce the need for follow-up biopsies.